APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Sustained-Release Tablet

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Felodipine Sustained-Release Tablet Market Analysis and Forecast 2026-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchFelodipine Sustained-Release Tablet Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Sustained-Release Tablet Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Felodipine Sustained-Release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Sustained-Release Tablet Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Sustained-Release Tablet Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Sustained-Release Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Felodipine Sustained-Release Tablet include SHANXI KANGBO BIOLOGICAL PRODUCT, Sandoz, NanJing Easeheal Phaemaecutical, Mylan, Lifeon, Changzhou Siyao Pharmaceutical and Astrazeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Felodipine Sustained-Release Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Felodipine Sustained-Release Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Felodipine Sustained-Release Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Felodipine Sustained-Release Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Felodipine Sustained-Release Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Felodipine Sustained-Release Tablet sales, projected growth trends, production technology, application and end-user industry.

Felodipine Sustained-Release Tablet Segment by Company

SHANXI KANGBO BIOLOGICAL PRODUCT

Sandoz

NanJing Easeheal Phaemaecutical

Mylan

Lifeon

Changzhou Siyao Pharmaceutical

Astrazeneca

Felodipine Sustained-Release Tablet Segment by Type

2.5mg Per Tablet

5mg Per Tablet

Others

Felodipine Sustained-Release Tablet Segment by Application

Treat High Blood Pressure

Relieve Angina

Others

Felodipine Sustained-Release Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Sustained-Release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Sustained-Release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Sustained-Release Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Felodipine Sustained-Release Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Felodipine Sustained-Release Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Felodipine Sustained-Release Tablet sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2.5mg Per Tablet Major Manufacturers Table 3. 5mg Per Tablet Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Treat High Blood Pressure Major Manufacturers Table 7. Relieve Angina Major Manufacturers Table 8. Others Major Manufacturers Table 9. Felodipine Sustained-Release Tablet Industry Trends Table 10. Felodipine Sustained-Release Tablet Industry Drivers Table 11. Felodipine Sustained-Release Tablet Industry Opportunities and Challenges Table 12. Felodipine Sustained-Release Tablet Industry Restraints Table 13. Global Felodipine Sustained-Release Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Felodipine Sustained-Release Tablet Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Felodipine Sustained-Release Tablet Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2021-2026) Table 17. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2027-2032) Table 18. Global Felodipine Sustained-Release Tablet Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Felodipine Sustained-Release Tablet Sales by Region (2021-2026) & (K Units) Table 20. Global Felodipine Sustained-Release Tablet Sales by Region (2027-2032) & (K Units) Table 21. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2021-2026) Table 22. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2027-2032) Table 23. Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Felodipine Sustained-Release Tablet Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2021-2026) Table 27. Global Felodipine Sustained-Release Tablet Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Felodipine Sustained-Release Tablet Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Felodipine Sustained-Release Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Felodipine Sustained-Release Tablet Manufacturers, Product Type & Application Table 31. Global Felodipine Sustained-Release Tablet Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Felodipine Sustained-Release Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Felodipine Sustained-Release Tablet Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Felodipine Sustained-Release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Felodipine Sustained-Release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2021-2026) Table 38. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2027-2032) Table 39. Global Felodipine Sustained-Release Tablet Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 41. Global Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 42. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2021-2026) Table 43. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2027-2032) Table 44. Global Felodipine Sustained-Release Tablet Price by Type (2021-2026) & (US$/Unit) Table 45. Global Felodipine Sustained-Release Tablet Price by Type (2027-2032) & (US$/Unit) Table 46. Global Felodipine Sustained-Release Tablet Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Felodipine Sustained-Release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Felodipine Sustained-Release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2021-2026) Table 50. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2027-2032) Table 51. Global Felodipine Sustained-Release Tablet Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 53. Global Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 54. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2021-2026) Table 55. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2027-2032) Table 56. Global Felodipine Sustained-Release Tablet Price by Application (2021-2026) & (US$/Unit) Table 57. Global Felodipine Sustained-Release Tablet Price by Application (2027-2032) & (US$/Unit) Table 58. SHANXI KANGBO BIOLOGICAL PRODUCT Company Information Table 59. SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview Table 60. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio Table 62. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Development Table 63. Sandoz Company Information Table 64. Sandoz Business Overview Table 65. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sandoz Felodipine Sustained-Release Tablet Product Portfolio Table 67. Sandoz Recent Development Table 68. NanJing Easeheal Phaemaecutical Company Information Table 69. NanJing Easeheal Phaemaecutical Business Overview Table 70. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio Table 72. NanJing Easeheal Phaemaecutical Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Mylan Felodipine Sustained-Release Tablet Product Portfolio Table 77. Mylan Recent Development Table 78. Lifeon Company Information Table 79. Lifeon Business Overview Table 80. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Lifeon Felodipine Sustained-Release Tablet Product Portfolio Table 82. Lifeon Recent Development Table 83. Changzhou Siyao Pharmaceutical Company Information Table 84. Changzhou Siyao Pharmaceutical Business Overview Table 85. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio Table 87. Changzhou Siyao Pharmaceutical Recent Development Table 88. Astrazeneca Company Information Table 89. Astrazeneca Business Overview Table 90. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio Table 92. Astrazeneca Recent Development Table 93. North America Felodipine Sustained-Release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Felodipine Sustained-Release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 96. North America Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 97. North America Felodipine Sustained-Release Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America Felodipine Sustained-Release Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America Felodipine Sustained-Release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Felodipine Sustained-Release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 102. North America Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 103. North America Felodipine Sustained-Release Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America Felodipine Sustained-Release Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 110. North America Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 111. North America Felodipine Sustained-Release Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America Felodipine Sustained-Release Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 114. Canada Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 115. Europe Felodipine Sustained-Release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Felodipine Sustained-Release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 118. Europe Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 119. Europe Felodipine Sustained-Release Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 120. Europe Felodipine Sustained-Release Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 121. Europe Felodipine Sustained-Release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Felodipine Sustained-Release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 124. Europe Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 125. Europe Felodipine Sustained-Release Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 126. Europe Felodipine Sustained-Release Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Europe Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. Europe Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 132. Europe Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 133. Europe Felodipine Sustained-Release Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 134. Europe Felodipine Sustained-Release Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 135. Germany Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 136. France Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 137. U.K. Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 138. Italy Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 139. Netherlands Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 140. Nordic Countries Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 141. China Felodipine Sustained-Release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 142. China Felodipine Sustained-Release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 143. China Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 144. China Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 145. China Felodipine Sustained-Release Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 146. China Felodipine Sustained-Release Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 147. China Felodipine Sustained-Release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 148. China Felodipine Sustained-Release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 149. China Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 150. China Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 151. China Felodipine Sustained-Release Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 152. China Felodipine Sustained-Release Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Felodipine Sustained-Release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Felodipine Sustained-Release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 156. Asia Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 157. Asia Felodipine Sustained-Release Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 158. Asia Felodipine Sustained-Release Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 159. Asia Felodipine Sustained-Release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Felodipine Sustained-Release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 162. Asia Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 163. Asia Felodipine Sustained-Release Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 164. Asia Felodipine Sustained-Release Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. Asia Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 170. Asia Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 171. Asia Felodipine Sustained-Release Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 172. Asia Felodipine Sustained-Release Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Japan Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 174. South Korea Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 175. India Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 176. Australia Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 177. China Taiwan Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Felodipine Sustained-Release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Felodipine Sustained-Release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 182. SAMEA Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 183. SAMEA Felodipine Sustained-Release Tablet Sales Price by Type (2021-2026) & (US$/Unit) Table 184. SAMEA Felodipine Sustained-Release Tablet Sales Price by Type (2027-2032) & (US$/Unit) Table 185. SAMEA Felodipine Sustained-Release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Felodipine Sustained-Release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 188. SAMEA Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 189. SAMEA Felodipine Sustained-Release Tablet Sales Price by Application (2021-2026) & (US$/Unit) Table 190. SAMEA Felodipine Sustained-Release Tablet Sales Price by Application (2027-2032) & (US$/Unit) Table 191. SAMEA Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 195. SAMEA Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 196. SAMEA Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 197. SAMEA Felodipine Sustained-Release Tablet Sales Price by Country (2021-2026) & (US$/Unit) Table 198. SAMEA Felodipine Sustained-Release Tablet Sales Price by Country (2027-2032) & (US$/Unit) Table 199. Brazil Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 200. Argentina Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 201. Chile Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 202. Colombia Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 203. Peru Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 205. Israel Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 206. UAE Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 207. Turkey Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 208. Iran Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 209. Egypt Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Felodipine Sustained-Release Tablet Distributors List Table 213. Felodipine Sustained-Release Tablet Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Felodipine Sustained-Release Tablet Image Figure 2. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Sustained-Release Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2.5mg Per Tablet Image Figure 5. 5mg Per Tablet Image Figure 6. Others Image Figure 7. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Felodipine Sustained-Release Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 9. Treat High Blood Pressure Image Figure 10. Relieve Angina Image Figure 11. Others Image Figure 12. Global Felodipine Sustained-Release Tablet Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Figure 14. Global Felodipine Sustained-Release Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2021-2032) Figure 17. Global Felodipine Sustained-Release Tablet Sales (2021-2032) & (K Units) Figure 18. Global Felodipine Sustained-Release Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Felodipine Sustained-Release Tablet Sales YoY (2021-2032) & (K Units) Figure 21. Europe Felodipine Sustained-Release Tablet Sales YoY (2021-2032) & (K Units) Figure 22. China Felodipine Sustained-Release Tablet Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Felodipine Sustained-Release Tablet Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales YoY (2021-2032) & (K Units) Figure 25. Global Felodipine Sustained-Release Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Felodipine Sustained-Release Tablet Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Felodipine Sustained-Release Tablet Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2021-2032) Figure 31. Global Felodipine Sustained-Release Tablet Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Felodipine Sustained-Release Tablet Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2021-2032) Figure 34. Global Felodipine Sustained-Release Tablet Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2021-2032) Figure 37. Global Felodipine Sustained-Release Tablet Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Felodipine Sustained-Release Tablet Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2021-2032) Figure 40. North America Felodipine Sustained-Release Tablet Revenue Share by Type (2021-2032) Figure 41. North America Felodipine Sustained-Release Tablet Sales Share by Type (2021-2032) Figure 42. North America Felodipine Sustained-Release Tablet Revenue Share by Application (2021-2032) Figure 43. North America Felodipine Sustained-Release Tablet Sales Share by Application (2021-2032) Figure 44. North America Felodipine Sustained-Release Tablet Revenue Share by Country (2021-2032) Figure 45. North America Felodipine Sustained-Release Tablet Sales Share by Country (2021-2032) Figure 46. Europe Felodipine Sustained-Release Tablet Revenue Share by Type (2021-2032) Figure 47. Europe Felodipine Sustained-Release Tablet Sales Share by Type (2021-2032) Figure 48. Europe Felodipine Sustained-Release Tablet Revenue Share by Application (2021-2032) Figure 49. Europe Felodipine Sustained-Release Tablet Sales Share by Application (2021-2032) Figure 50. Europe Felodipine Sustained-Release Tablet Revenue Share by Country (2021-2032) Figure 51. Europe Felodipine Sustained-Release Tablet Sales Share by Country (2021-2032) Figure 52. China Felodipine Sustained-Release Tablet Revenue Share by Type (2021-2032) Figure 53. China Felodipine Sustained-Release Tablet Sales Share by Type (2021-2032) Figure 54. China Felodipine Sustained-Release Tablet Revenue Share by Application (2021-2032) Figure 55. China Felodipine Sustained-Release Tablet Sales Share by Application (2021-2032) Figure 56. Asia Felodipine Sustained-Release Tablet Revenue Share by Type (2021-2032) Figure 57. Asia Felodipine Sustained-Release Tablet Sales Share by Type (2021-2032) Figure 58. Asia Felodipine Sustained-Release Tablet Revenue Share by Application (2021-2032) Figure 59. Asia Felodipine Sustained-Release Tablet Sales Share by Application (2021-2032) Figure 60. Asia Felodipine Sustained-Release Tablet Revenue Share by Country (2021-2032) Figure 61. Asia Felodipine Sustained-Release Tablet Sales Share by Country (2021-2032) Figure 62. SAMEA Felodipine Sustained-Release Tablet Revenue Share by Type (2021-2032) Figure 63. SAMEA Felodipine Sustained-Release Tablet Sales Share by Type (2021-2032) Figure 64. SAMEA Felodipine Sustained-Release Tablet Revenue Share by Application (2021-2032) Figure 65. SAMEA Felodipine Sustained-Release Tablet Sales Share by Application (2021-2032) Figure 66. SAMEA Felodipine Sustained-Release Tablet Revenue Share by Country (2021-2032) Figure 67. SAMEA Felodipine Sustained-Release Tablet Sales Share by Country (2021-2032) Figure 68. Felodipine Sustained-Release Tablet Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Felodipine Sustained-Release Tablet Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg Per Tablet
  • 5mg Per Tablet
  • Others
Applications
  • Treat High Blood Pressure
  • Relieve Angina
  • Others
Companies covered
  • SHANXI KANGBO BIOLOGICAL PRODUCT
  • Sandoz
  • NanJing Easeheal Phaemaecutical
  • Mylan
  • Lifeon
  • Changzhou Siyao Pharmaceutical
  • Astrazeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Felodipine Sustained-Release Tablet Market by Type
  3. 1.2.1 Global Felodipine Sustained-Release Tablet Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2.5mg Per Tablet
  5. 1.2.3 5mg Per Tablet
  6. 1.2.4 Others
  7. 1.3 Felodipine Sustained-Release Tablet Market by Application
  8. 1.3.1 Global Felodipine Sustained-Release Tablet Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Treat High Blood Pressure
  10. 1.3.3 Relieve Angina
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Felodipine Sustained-Release Tablet Market Dynamics
  1. 2.1 Felodipine Sustained-Release Tablet Industry Trends
  2. 2.2 Felodipine Sustained-Release Tablet Industry Drivers
  3. 2.3 Felodipine Sustained-Release Tablet Industry Opportunities and Challenges
  4. 2.4 Felodipine Sustained-Release Tablet Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Felodipine Sustained-Release Tablet Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Felodipine Sustained-Release Tablet Revenue by Region
  3. 3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Felodipine Sustained-Release Tablet Revenue by Region (2021-2026)
  5. 3.2.3 Global Felodipine Sustained-Release Tablet Revenue by Region (2027-2032)
  6. 3.2.4 Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Felodipine Sustained-Release Tablet Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Felodipine Sustained-Release Tablet Sales by Region
  9. 3.4.1 Global Felodipine Sustained-Release Tablet Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Felodipine Sustained-Release Tablet Sales by Region (2021-2026)
  11. 3.4.3 Global Felodipine Sustained-Release Tablet Sales by Region (2027-2032)
  12. 3.4.4 Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Felodipine Sustained-Release Tablet Revenue by Manufacturers
  2. 4.1.1 Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Felodipine Sustained-Release Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Felodipine Sustained-Release Tablet Sales by Manufacturers
  6. 4.2.1 Global Felodipine Sustained-Release Tablet Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Felodipine Sustained-Release Tablet Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Felodipine Sustained-Release Tablet Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Felodipine Sustained-Release Tablet Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Felodipine Sustained-Release Tablet Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Felodipine Sustained-Release Tablet Manufacturers, Product Type & Application
  13. 4.7 Global Felodipine Sustained-Release Tablet Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Felodipine Sustained-Release Tablet Market CR5 and HHI
  16. 4.8.2 2025 Felodipine Sustained-Release Tablet Tier 1, Tier 2, and Tier 3
5 Felodipine Sustained-Release Tablet Market by Type
  1. 5.1 Global Felodipine Sustained-Release Tablet Revenue by Type
  2. 5.1.1 Global Felodipine Sustained-Release Tablet Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Felodipine Sustained-Release Tablet Sales by Type
  6. 5.2.1 Global Felodipine Sustained-Release Tablet Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felodipine Sustained-Release Tablet Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2021-2032)
  9. 5.3 Global Felodipine Sustained-Release Tablet Price by Type
6 Felodipine Sustained-Release Tablet Market by Application
  1. 6.1 Global Felodipine Sustained-Release Tablet Revenue by Application
  2. 6.1.1 Global Felodipine Sustained-Release Tablet Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Felodipine Sustained-Release Tablet Sales by Application
  6. 6.2.1 Global Felodipine Sustained-Release Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Felodipine Sustained-Release Tablet Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2021-2032)
  9. 6.3 Global Felodipine Sustained-Release Tablet Price by Application
7 Company Profiles
  1. 7.1 SHANXI KANGBO BIOLOGICAL PRODUCT
  2. 7.1.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
  3. 7.1.2 SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview
  4. 7.1.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio
  6. 7.1.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Felodipine Sustained-Release Tablet Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 NanJing Easeheal Phaemaecutical
  14. 7.3.1 NanJing Easeheal Phaemaecutical Company Information
  15. 7.3.2 NanJing Easeheal Phaemaecutical Business Overview
  16. 7.3.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio
  18. 7.3.5 NanJing Easeheal Phaemaecutical Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Felodipine Sustained-Release Tablet Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Lifeon
  26. 7.5.1 Lifeon Company Information
  27. 7.5.2 Lifeon Business Overview
  28. 7.5.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lifeon Felodipine Sustained-Release Tablet Product Portfolio
  30. 7.5.5 Lifeon Recent Developments
  31. 7.6 Changzhou Siyao Pharmaceutical
  32. 7.6.1 Changzhou Siyao Pharmaceutical Company Information
  33. 7.6.2 Changzhou Siyao Pharmaceutical Business Overview
  34. 7.6.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio
  36. 7.6.5 Changzhou Siyao Pharmaceutical Recent Developments
  37. 7.7 Astrazeneca
  38. 7.7.1 Astrazeneca Company Information
  39. 7.7.2 Astrazeneca Business Overview
  40. 7.7.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio
  42. 7.7.5 Astrazeneca Recent Developments
8 North America
  1. 8.1 North America Felodipine Sustained-Release Tablet Market Size by Type
  2. 8.1.1 North America Felodipine Sustained-Release Tablet Revenue by Type (2021-2032)
  3. 8.1.2 North America Felodipine Sustained-Release Tablet Sales by Type (2021-2032)
  4. 8.1.3 North America Felodipine Sustained-Release Tablet Price by Type (2021-2032)
  5. 8.2 North America Felodipine Sustained-Release Tablet Market Size by Application
  6. 8.2.1 North America Felodipine Sustained-Release Tablet Revenue by Application (2021-2032)
  7. 8.2.2 North America Felodipine Sustained-Release Tablet Sales by Application (2021-2032)
  8. 8.2.3 North America Felodipine Sustained-Release Tablet Price by Application (2021-2032)
  9. 8.3 North America Felodipine Sustained-Release Tablet Market Size by Country
  10. 8.3.1 North America Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Felodipine Sustained-Release Tablet Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Felodipine Sustained-Release Tablet Market Size by Type
  2. 9.1.1 Europe Felodipine Sustained-Release Tablet Revenue by Type (2021-2032)
  3. 9.1.2 Europe Felodipine Sustained-Release Tablet Sales by Type (2021-2032)
  4. 9.1.3 Europe Felodipine Sustained-Release Tablet Price by Type (2021-2032)
  5. 9.2 Europe Felodipine Sustained-Release Tablet Market Size by Application
  6. 9.2.1 Europe Felodipine Sustained-Release Tablet Revenue by Application (2021-2032)
  7. 9.2.2 Europe Felodipine Sustained-Release Tablet Sales by Application (2021-2032)
  8. 9.2.3 Europe Felodipine Sustained-Release Tablet Price by Application (2021-2032)
  9. 9.3 Europe Felodipine Sustained-Release Tablet Market Size by Country
  10. 9.3.1 Europe Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Felodipine Sustained-Release Tablet Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Felodipine Sustained-Release Tablet Market Size by Type
  2. 10.1.1 China Felodipine Sustained-Release Tablet Revenue by Type (2021-2032)
  3. 10.1.2 China Felodipine Sustained-Release Tablet Sales by Type (2021-2032)
  4. 10.1.3 China Felodipine Sustained-Release Tablet Price by Type (2021-2032)
  5. 10.2 China Felodipine Sustained-Release Tablet Market Size by Application
  6. 10.2.1 China Felodipine Sustained-Release Tablet Revenue by Application (2021-2032)
  7. 10.2.2 China Felodipine Sustained-Release Tablet Sales by Application (2021-2032)
  8. 10.2.3 China Felodipine Sustained-Release Tablet Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Felodipine Sustained-Release Tablet Market Size by Type
  2. 11.1.1 Asia Felodipine Sustained-Release Tablet Revenue by Type (2021-2032)
  3. 11.1.2 Asia Felodipine Sustained-Release Tablet Sales by Type (2021-2032)
  4. 11.1.3 Asia Felodipine Sustained-Release Tablet Price by Type (2021-2032)
  5. 11.2 Asia Felodipine Sustained-Release Tablet Market Size by Application
  6. 11.2.1 Asia Felodipine Sustained-Release Tablet Revenue by Application (2021-2032)
  7. 11.2.2 Asia Felodipine Sustained-Release Tablet Sales by Application (2021-2032)
  8. 11.2.3 Asia Felodipine Sustained-Release Tablet Price by Application (2021-2032)
  9. 11.3 Asia Felodipine Sustained-Release Tablet Market Size by Country
  10. 11.3.1 Asia Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Felodipine Sustained-Release Tablet Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Felodipine Sustained-Release Tablet Market Size by Type
  2. 12.1.1 SAMEA Felodipine Sustained-Release Tablet Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Felodipine Sustained-Release Tablet Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Felodipine Sustained-Release Tablet Price by Type (2021-2032)
  5. 12.2 SAMEA Felodipine Sustained-Release Tablet Market Size by Application
  6. 12.2.1 SAMEA Felodipine Sustained-Release Tablet Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Felodipine Sustained-Release Tablet Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Felodipine Sustained-Release Tablet Price by Application (2021-2032)
  9. 12.3 SAMEA Felodipine Sustained-Release Tablet Market Size by Country
  10. 12.3.1 SAMEA Felodipine Sustained-Release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Felodipine Sustained-Release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Felodipine Sustained-Release Tablet Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Felodipine Sustained-Release Tablet Value Chain Analysis
  2. 13.1.1 Felodipine Sustained-Release Tablet Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Felodipine Sustained-Release Tablet Production Mode & Process
  6. 13.2 Felodipine Sustained-Release Tablet Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Felodipine Sustained-Release Tablet Distributors
  9. 13.2.3 Felodipine Sustained-Release Tablet Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst